Table 1 Distribution of ovarian carcinoma histotypes according to historical 2002 review, current 2014 re-review by pathologist A, and 2014 independent review by pathologist B
From: Ovarian carcinoma diagnosis: the clinical impact of 15 years of change
Pathologist A 2002/WHO, 1999 | Pathologist A 2014/WHO, 2014 | Pathologist B 2014/WHO, 2014 | ||||||
|---|---|---|---|---|---|---|---|---|
Serous G1/G2/G3 | n=131 | 46% | HGSC | n=229 | 80% | HGSC | n=233 | 81% |
EC | n=52 | 18% | LGSC | n=21 | 7% | LGSC | n=21 | 7% |
CCC | n=35 | 12% | EC | n=14 | 5% | EC | n=10 | 4% |
Undifferentiated | n=31 | 11% | CCC | n=13 | 5% | CCC | n=13 | 5% |
MC | n=23 | 8% | MC | n=9 | 3% | MC | n=9 | 3% |
TCC | n=14 | 5% | ||||||
